Zacks Investment Research on MSN
Owlet vs. Masimo: Which medical monitoring stock is the better buy?
Remote and continuous patient monitoring is moving from a niche capability to a core pillar of modern healthcare, driven by ...
Masimo Corp. urged a California federal judge to reject Apple Inc.’s bid to erase a $634 million patent-infringement verdict over Apple Watch heart-rate alerts, arguing trial evidence supported the ...
Masimo Corp. has urged a California federal judge to reject Apple’s bid to erase a US$634 million patent-infringement verdict ...
Masimo (Nasdaq:MASI) has opposed an attempt by Apple to overturn the recent patent infringement ruling ordering it to pay $634 million.
Universal Surveillance Monitoring with Masimo SET ® Pulse Oximetry and Patient SafetyNet™ – Repeatedly Shown to Improve Patient Outcomes and Save Lives – Also Projected to Yield Significant Cost ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI), a global leader in innovative monitoring technologies used in top hospitals, announced today FDA clearance of Stork™, a revolutionary baby ...
Irvine, California-based Masimo, makers of a suite of non-invasive patient monitoring devices and sensors, has expanded the capabilities of its connected platform to allow physicians to view more data ...
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that Vanderbilt University Medical Center (VUMC), a renowned healthcare facility in Nashville, Tennessee, is piloting the use of ...
Zacks Investment Research on MSN
Here's why you should retain Masimo stock in your portfolio now
Masimo Corporation MASI is well-poised for growth in the coming quarters, courtesy of its strong underlying demand for innovative technology and research and development (R&D) efforts. The optimism, ...
Files Revised Definitive Proxy Materials and Mails Letter to Stockholders Urges Stockholders to Vote “FOR” Only Masimo’s Director Nominees, Joe Kiani and Christopher Chavez, on the Updated GOLD Proxy ...
Masimo Corp. is sponsoring a new clinical study titled “Philips FAST SpO2 Technology With Masimo Sensors for SpO2 Monitoring in the Neonatal, Infant, and Pediatric Populations.” The goal is to confirm ...
Masimo’s Rainbow Acoustic Monitoring sensor, RAS-125 Acoustic Respiration Cloth Sensor, was granted FDA 510(k) clearance for monitoring pediatric patients. Previously, clinicians could only use the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results